Starton Therapeutics

About:

Starton Therapeutics is a biotechnology company that focuses on transforming standard of care in therapeutics.

Website: https://startontx.com

Twitter/X: startontx

Description:

Starton Therapeutics is a biotechnology company that focuses on transforming the standard of care in therapeutics. The company develops a transdermal patch technology created to transform chemotherapy-induced nausea and vomiting. It uses proven transdermal technology with proprietary drivers to obtain new indications or develop on-label superiority for patients with hematological malignancies.

Total Funding Amount:

$10.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2017-01-01

Contact Email:

contact(AT)chemio.care

Founders:

Pedro Lichtinger

Number of Employees:

11-50

Last Funding Date:

2024-10-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai